New vaccine could stop recurring yeast infections in their tracks
NCT ID NCT06190509
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new vaccine called Candi5V in 251 women who get frequent yeast infections (at least 3 per year). The vaccine is designed to train the body's immune system to fight Candida fungus. Researchers will check if it's safe and if it reduces future infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT VULVOVAGINAL CANDIDIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aidport sp.z o.o.
Skórzewo, Poznan, 60-185, Poland
-
Femicare
Tienen, Tienen, 3300, Belgium
-
IN-VIVO Sp. z o.o.
Bydgoszcz, 85-048, Poland
-
MTZ Clinical Research powered by Pratia
Warsaw, 02-172, Poland
-
NZOZ Medem
Katowice, 40-301, Poland
-
Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
-
Velocity Nova sp. z o.o
Lublin, 20-362, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.